Prostate Cancer Drug Reduces Testosterone Levels In As Little As Three Days Without Initial Hormone Surge

More than 95 per cent of men who took degarelix for prostate cancer saw their testosterone levels fall dramatically as early as three days after they started treatment, according to a new article.